Neuro-Oncology Associates' mission is to treat each patient as an individual and provide comprehensive, compassionate, and innovative tumor care that will lead to the best possible outcome.
Dr. Karen Fink strives to incorporate the latest in clinical trials and treatment options where appropriate so that our patients will sustain hope for positive outcomes and an improved quality of care.
Dr. Isaac Melguizo-Gavilanes’
last day with Neuro-Oncology Associates will now be May 18, 2017. The
providers and staff at Neuro-Oncology Associates will assume responsibility for
Dr. Melguizo’s patients. Should you have any questions, please ask to speak
with Kesha Crites (Practice Manager) or Jennifer Morrill (Social Worker).
Neuro-Oncology Associates offer diagnosis and treatment for neurological complications of cancer and chemotherapy. An estimated 15 to 20 percent of cancer patients have symptomatic neurologic complications during the course of their illness. The most common complaints are back pain, mental status changes, headache, limb pain, and leg weakness.
Neuro-Oncology Associates is proud to include their patients as part of their care team. Patients and their families (if desired) are encouraged to participate in the development of their own individualized treatment plan. Together, with their patients, Neuro-Oncology Associates will work to produce the best possible outcome for each patient's specific diagnosis.
Brain tumors are classified depending on the exact site of the tumor, the type of tissue involved, whether they are noncancerous (benign) or cancerous (malignant), and other factors.
At Neuro-Oncology Associates, tumors of the brain, central nervous system, and peripheral nervous system are treated with dedication, innovation, and quality care.
Active and Upcoming Clinical Trials
Monday - Friday
8:00 a.m. - 5:00 p.m.